Subscribe
novikov-alex-shutterstock-com
Novikov Alex / Shutterstock.com
20 April 2015Americas

Allergan sued for promoting off-label Botox use

An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox (onabotulinumtoxinA) to treat back pain.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.
Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
USITC to investigate Daewoong following Allergan complaint
4 March 2019   The US International Trade Commission has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.
Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
USITC to investigate Daewoong following Allergan complaint
4 March 2019   The US International Trade Commission has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.

More on this story

Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.
Big Pharma
PTAB invalidates Medytox Botox patent
20 July 2021   The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Americas
USITC to investigate Daewoong following Allergan complaint
4 March 2019   The US International Trade Commission has begun an investigation into Daewoong Pharmaceuticals of South Korea and California-based Evolus, following a complaint from Allergan.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler